The lung microbiota is considered to be connected with specific insults related to lung cancer via CD36, which regulates the treatment of cyanobacteria-derived microcystin residues in the lung alveoli, upregulating the expression of poly (ADP-ribose) polymerase 1 (PARP1) 64. Here, PARP1 is linked to lung carcinoma.